AU532023B2 - 1(2h)-isoquinolone compounds - Google Patents

1(2h)-isoquinolone compounds

Info

Publication number
AU532023B2
AU532023B2 AU61609/80A AU6160980A AU532023B2 AU 532023 B2 AU532023 B2 AU 532023B2 AU 61609/80 A AU61609/80 A AU 61609/80A AU 6160980 A AU6160980 A AU 6160980A AU 532023 B2 AU532023 B2 AU 532023B2
Authority
AU
Australia
Prior art keywords
isoquinolone compounds
isoquinolone
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU61609/80A
Other languages
English (en)
Other versions
AU6160980A (en
Inventor
Kosuke Fujiwara
Eiichi Kato
Hidekazu Miyake
Osamu Ohtani
Shigeo Senda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruko Pharmaceutical Co Ltd
Taiho Pharmaceutical Co Ltd
Original Assignee
Maruko Pharmaceutical Co Ltd
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruko Pharmaceutical Co Ltd, Taiho Pharmaceutical Co Ltd filed Critical Maruko Pharmaceutical Co Ltd
Publication of AU6160980A publication Critical patent/AU6160980A/en
Application granted granted Critical
Publication of AU532023B2 publication Critical patent/AU532023B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU61609/80A 1979-08-21 1980-08-21 1(2h)-isoquinolone compounds Ceased AU532023B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10549779A JPS5677261A (en) 1979-08-21 1979-08-21 1 2h isoquinolone derivative and its acid addition salt
JP10549779 1979-08-21

Publications (2)

Publication Number Publication Date
AU6160980A AU6160980A (en) 1981-04-09
AU532023B2 true AU532023B2 (en) 1983-09-15

Family

ID=14409228

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61609/80A Ceased AU532023B2 (en) 1979-08-21 1980-08-21 1(2h)-isoquinolone compounds

Country Status (10)

Country Link
JP (1) JPS5677261A (de)
AU (1) AU532023B2 (de)
CA (1) CA1153763A (de)
CH (1) CH646953A5 (de)
DE (1) DE3031574A1 (de)
ES (1) ES494891A0 (de)
FR (1) FR2463766A1 (de)
GB (1) GB2058783B (de)
IT (1) IT1188988B (de)
NL (1) NL8004736A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2098980B (en) * 1981-03-28 1985-05-15 Taiho Pharmaceutical Co Ltd 1(2h)-isoquinolone compounds and acid addition salts thereof
JPS58164577A (ja) * 1982-03-24 1983-09-29 Taiho Yakuhin Kogyo Kk ４―ベンジル―１―（２ｈ）イソキノロン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3600394A (en) * 1968-05-17 1971-08-17 Searle & Co 2-aminoalkyl-3-arylisocarbostyrils
SE368009B (de) * 1971-09-16 1974-06-17 Kabi Ab
US3928612A (en) * 1974-10-02 1975-12-23 American Home Prod 1,2-Dihydro- and 1,2,3,4-tetrahydro-1-oxo-3-isoquinolinecarboxylic acid derivatives as anti-allergic agents

Also Published As

Publication number Publication date
ES8106501A1 (es) 1981-09-01
GB2058783A (en) 1981-04-15
FR2463766A1 (fr) 1981-02-27
CH646953A5 (de) 1984-12-28
CA1153763A (en) 1983-09-13
IT1188988B (it) 1988-01-28
IT8049519A1 (it) 1982-02-19
AU6160980A (en) 1981-04-09
GB2058783B (en) 1983-04-07
IT8049519A0 (it) 1980-08-19
ES494891A0 (es) 1981-09-01
NL8004736A (nl) 1981-02-24
FR2463766B1 (de) 1983-09-02
DE3031574A1 (de) 1981-03-12
JPS5677261A (en) 1981-06-25

Similar Documents

Publication Publication Date Title
AU539785B2 (en) 2-penem compounds
JPS5594363A (en) Phenoxyphenylpiperidine compound
AU520536B2 (en) Pyridazone compounds
JPS5610183A (en) 199hydroxyypgi compound
AU529934B2 (en) Substituted tetraazatricyclic compounds
JPS55143971A (en) 144methoxymorphinann66one compound
JPS56113779A (en) Compound
AU6179480A (en) Polyazathia compounds
JPS567790A (en) Novel penicillinn1*11dioxide compound
AU6011480A (en) 7 aminothiadiazoylacetamido - cephalosporins
AU5635580A (en) Diazatricyclic compounds
AU531142B2 (en) 2 amino- pyimindones
JPS5667369A (en) Phthaloperinone compound
JPS5594364A (en) Phenylthiophenylpiperidine compound
GB2043060B (en) 4-substituted 2-iminoimidazolidine compounds
AU532023B2 (en) 1(2h)-isoquinolone compounds
ZA802765B (en) Novel compounds
JPS55127385A (en) 9*111dideoxyy100oxaatxb compounds
JPS55147293A (en) Novel thiazolinoazetidinone compound
JPS55136264A (en) Pyridineacetoamide compound
JPS5634678A (en) Pyridazinone compound
AU530504B2 (en) 1-styrylmethylimidazole compounds
AU6539980A (en) 2-oxybenzimidazoline compounds
JPS5632575A (en) Antiifreeze compound
JPS56100858A (en) Halootriazinyl compound